Effects of Danhong Injection on Protect Myocardium of Acute Coronary Syndrome Patients after Selective Percutaneous Coronary Artery Intervention

ZHANG Yong-xiang; ZHANG Qiang

您当前的位置：

首页 >

文章列表页 >

Effects of Danhong Injection on Protect Myocardium of Acute Coronary Syndrome Patients after Selective Percutaneous Coronary Artery Intervention

更新时间：2024-01-04

- Effects of Danhong Injection on Protect Myocardium of Acute Coronary Syndrome Patients after Selective Percutaneous Coronary Artery Intervention
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 18, Issue 23, Pages: 308-311(2012)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2012
- 稿件说明：
移动端阅览
ZHANG Yong-xiang, ZHANG Qiang. Effects of Danhong Injection on Protect Myocardium of Acute Coronary Syndrome Patients after Selective Percutaneous Coronary Artery Intervention[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(23): 308-311.
DOI：

ZHANG Yong-xiang, ZHANG Qiang. Effects of Danhong Injection on Protect Myocardium of Acute Coronary Syndrome Patients after Selective Percutaneous Coronary Artery Intervention[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(23): 308-311. DOI：

摘要

目的: 观察丹红注射液对行经皮冠状动脉介入治疗(PCI)的急性冠脉综合征(ACS)患者心肌的保护作用。方法: 采用前瞻性试验设计

将68例拟行PCI治疗的ACS患者按随机数字表法分为治疗组和对照组

两组各34例患者。均给予常规治疗

治疗组加用丹红注射液40 mL

同时纳入本院健康体检者40例作为健康组。观察所有被试PCI术前、术后即刻、治疗14 d的血浆内皮素-1(ET-1)、P选择素(CD62p)、高敏C反应蛋白(hs-CRP)、治疗7 d后ST段回落率。采用 SAS 9.0统计学软件对数据进行统计学分析。结果: ACS患者术前的血浆ET-1

CD62p

hs-CRP均高于健康组

差异均有统计学意义(P＜0.05)

治疗组与对照组相比差异无统计学意义。治疗14 d后

两组患者ET-1

CD62p

hs-CRP水平均较治疗前下降

差异有统计学意义(P＜0.05);治疗组与对照组相比

治疗组ET-1

CD62p

hs-CRP均低于对照组

差异有统计学意义(P＜0.05)。治疗7 d后治疗组ST段回落率高于对照组

差异有统计学意义(P＜0.05)。结论: 丹红注射液可以抑制ASC患者PCI术后的炎症反应

保护内皮细胞

建议作为PCI术后保护心肌的治疗措施在临床推广。

Abstract

Objective: Explore the effects of Danhong injection on protect myocardium of acute coronary syndrome(ACS) patients after selective percutaneous coronary artery intervention(PCI). Method: Using a prospective design of experiments

the 68 patients of the intended line of PCI with ACS were randomly divided into treatment group and control group

each group is 34 patients. At the same time into the hospital health examination in 40 cases as health group.Observation the level of all patients of plasma endothelin-1(ET-1)

P-selectin (CD62p)

high enzyme C reactive protein (hs-CRP) and after treatment of 7 d ST segment resolution rate at PCI preoperatively

immediately after operation

treatment of 14 d. Using SPSS 9.0 statistical software for data statistics and analysis. Result: ACS patients preoperative plasma levels of ET-1

CD62p

hs-CRP were higher than the healthy group

The differences were statistically significant(P＜0.05). The treatment group compared with the control group

the difference was not statistically significant 14 days after treatment

two groups of patients with ET-1

CD62p

hs-CRP levels were decreased compared with those before treatment

the difference was statistically significant(P<0.05); The treatment group compared with the control group

treatment group

ET-1

CD62p

hs-CRP were lower than the control group

the difference was statistically significant(P<0.05). After treatment of 7 d

the treatment group ST segment resolution higher than that in the control group

the difference was statistically significant (P<0.05). Conclusion: Danhong injection can inhibit ASC in patients with PCI postoperative inflammatory reaction

protection of endothelial cells

is proposed as PCI postoperative myocardial protection measures in clinical treatment

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Treatment of Danhong Injection with Atorvastatin on Endothelial Function and Inflammation Factors in Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention

Efficacy-driving Mechanism of Danhong Injection for Stable Angina Pectoris Based on Composition-activity Relationship of Target Modules

Class-imbalance Prediction and High-dimensional Risk Factor Identification of Adverse Reactions of Traditional Chinese Medicine with Centralized Monitoring in Real-world Hospitals

Establishment and Evaluation of Rat Model of Acute Coronary Syndrome with Combined Blood Stasis and Poison

Research Progress on Pharmacological Mechanism of Danhong Injection in Treatment of Cardiovascular and Cerebrovascular Diseases

Related Author

GUO Jian-feng

WU Sheng-ben

YANG Jin-ping

SUN Guo-dong

WANG Yun-fan

ZONG Wenjing

LIU Jun

YANG Wei

Related Institution

Institute of Basic Theory for Chinese Medicine，China Academy of Chinese Medical Sciences

Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences

Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences， State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences

College of Art and Science，Boston University

College of Public Health and Health Professions，University of Florida

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰